Table 1

Overview of visits for phase 2

Time (weeks)	Visit	Test/action	Usual care arm	Intervention arm
	1	Consent, screening (medical history, clinical examination (height, weight, waist circumference, body fat and blood pressure), HbA1c, FBC, U+Es, LFTs, C peptide, fit activity monitor and continuous glucose monitor (if applicable), complete questionnaires (Hypoglycemia Fear Survey, Clarke’s Hypoglycemia Awareness, BAPAD, EQ-5D, PAID and T1-DDS). Provision of blood glucose and insulin diaries.	✔	✔
	2	Collection of activity monitor and continuous glucose monitor, and blood glucose monitor and insulin diaries.	✔	✔
Randomization by a researcher between visits 2 and 3
0–8	3	Education session 1	✔	✔
	4	Education session 2		✔
	5	Education session 3		✔
10–16	6	Joint nurse, doctor and dietitian appointment	✔	✔
26–33	7	6-month assessment, medical history, clinical examination (height, weight, waist circumference, body fat and blood pressure), HbA1c, FBC, U+Es, LFTs and diabetes-related autoantibodies, fit activity monitor and continuous glucose monitor (if applicable), complete questionnaires (Hypoglycemia Fear Survey, Clarke’s Hypoglycemia Awareness, BAPAD, EQ-5D, PAID and T1-DDS). Provision of blood glucose and insulin diaries.	✔	✔
28–34	8	Final visit. Collection of activity monitor and continuous glucose monitor (if applicable), and blood glucose monitor and insulin diaries.	✔	✔

BAPAD, Barriers to Physical Activity in Type 1 Diabetes; EQ-5D, EuroQol-5 Dimension; FBC, full blood count; LFT, liver function tests; PAID, Problem Areas in Diabetes scale; T1-DDS, Diabetes Distress Scale for Adults with Type 1 Diabetes; U+E, urea and electrolytes .